Satol, Basit S.
HRN: 09-91-44 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/22/2024
CEFTAZIDIME 1GM (VIAL)
04/22/2024
04/29/2024
IV
1gram
Q8
CAP, T/C PTB Relapse
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes